Reuters logo
BRIEF-3D Signatures says completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program
2017年10月10日 / 下午3点05分 / 9 天前

BRIEF-3D Signatures says completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

Oct 10 (Reuters) - 3d Signatures Inc:

* ‍On September 30, co completed clinical trial component or stage 3, of its Hodgkin’s Lymphoma Test Validation Program​

* Remain on track for expected commercial launch of Telo-HL(TM )as an LDT by end of Q1 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below